Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02871167 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation

Study acronym: CHACRY
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv8
  2. Primary completion date changed from estimate of Dec 2024 to Jun 5, 2024
    • Study completion date: Dec 2025 to Nov 2034
    v7
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 120 to confirmed 140
    • Site details revised at 28 of 28 sites
    v6
  4. Primary completion date: Dec 2020 to Dec 2024
    • Study completion date: Jun 2021 to Dec 2025
    v5
  5. Study sites revised (28)v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 1 to 28
    • Secondary endpoints: details revised at 1 of 8 entries
    • Study description expanded, about 4 words
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 7 more changesShow less
    • Start date: Sep 2016 to Dec 2016
    • Primary completion date: Sep 2020 to Dec 2020
    • Study completion date: Mar 2021 to Jun 2021
    • Eligibility criteria expanded, about 29 words
    • Secondary endpoints: 14 to 8
    • Study description expanded, about 13 words
    • Site details revised
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to perform a French multicenter prospective interventional study in order to assess the feasibility and safety of ovarian hyperstimulation for oocyte / embryo cryopreservation in young women with breast cancer. The oncologic and reproductive benefit / risk ratio will be investigated in the oncology and reproductive area.
Trial Details
NCT Number NCT02871167
Lead Sponsor Centre Oscar Lambret
Collaborators: University Hospital, Lille, National Cancer Institute, France, University Hospital, Montpellier
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov